Home Contact Sitemap

PedAM

Pediatric Disease Annotations & Medicines




Disease hematopoietic stem cell transplantation
Phenotype C0026764|myeloma
Sentences 5
PubMedID- 22690220 Although multiple myeloma remains incurable outside of allogeneic hematopoietic stem cell transplantation, novel agents made available only in the last few decades have nonetheless tremendously improved the landscape of myeloma treatment.
PubMedID- 26550130 The efficacy and safety of single-agent bortezomib or bortezomib-based regimens as consolidation therapy after autologous hematopoietic stem cell transplantation (asct) in patients with multiple myeloma (mm) has been in question.
PubMedID- 25830131 Further studies should target the identification of patients at high risk of hbv reactivation in multiple myeloma treated with autologous hematopoietic stem cell transplantation and steroid therapy for maintenance and establish viral prophylaxis strategies, especially in korea, in which hbv infection is endemic.
PubMedID- 26190662 Clinical features and survival of 338 multiple myeloma patients treated with hematopoietic stem cell transplantation or conventional chemotherapy.
PubMedID- 23436046 The purposes of this study were to evaluate the infection by hepatitis b virus (hbv) and its impact on survival and to provide a clinical reference for monitoring and treating hbv during and after autologous hematopoietic stem cell transplantation (asct) in patients with multiple myeloma (mm).

Page: 1